Resultaten visas 1 - 10 / 721
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Isolating Urinary Extracellular Vesicles as Biomarkers for Diabetic Disease

Referentgranskad
DOI
10.1007/978-1-4939-9841-8
Barreiro, Karina; Huber, Tobias B.; Holthöfer, Harry
Methods in Molecular Biology2020

1H NMR Metabonomics of Serum - Assessment of Molecular Indicators for Diabetic Nephropathy in Type 1 Diabetic Patients

Referentgranskad
Mäkinen, Ville-Petteri; Forsblom, Carol; Parkkonen, Maija; Soininen, Pasi; Kaski, Kimmo; Ala-Korpela...
-2006

Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum

Referentgranskad
DOI
10.1007/s10334-006-0054-y
Mäkinen, Ville-Petteri; Soininen, Pasi; Forsblom, Carol; Parkkonen, Maija; Ingman, Petri; Kaski, Kim...
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE2006

Luteolin attenuates diabetic nephropathy via inhibition of metalloenzymes in rats

Referentgranskad
Öppen tillgång
DOI
10.4103/2221-1691.391156
Daude Rakesh B., Bhadane Rajendra, Shah Jigna S.
Asian pacific journal of tropical biomedicine2023

Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes

Referentgranskad
Öppen tillgång
DOI
10.1111/joim.13298
Jansson Sigfrids, Fanny; Dahlström, Emma Helena; Forsblom, Carol; Sandholm, Niina; Harjutsalo, Valma...
Journal of internal medicine2021

Lipoproteins and Diabetic Nephropathy

Referentgranskad
DOI
10.1007/978-1-4614-7554-514
Makinen, Ville-Petteri; Tolonen, Nina; Groop, Per-Henrik
Humana press2014

Metabolic Phenotyping of Diabetic Nephropathy

Referentgranskad
Mäkinen Ville-Petteri, Kangas Antti J, Soininen Pasi, Würtz Peter, Groop Per-Henrik, Ala-Korpela Mik...
Clinical pharmacology and therapeutics2013

Metabolic phenotyping of diabetic nephropathy

Referentgranskad
DOI
10.1038/clpt.2013.158
Mäkinen, V P; Kangas, A J; Soininen, P; Würtz, P; Groop, P H; Ala-Korpela, M
Clinical pharmacology and therapeutics2013

Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.

Referentgranskad
Thorn LM, Forsblom C, Wadén J, Saraheimo M, Tolonen N, Hietala K, Groop PH; Finnish Diabetic Nephrop...
Diabetes care2009

The impact of diabetic nephropathy and severe diabetic retinopathy on chronic limb threatening ischemia risk in individuals with type 1 diabetes:a nationwide, population

Referentgranskad
Öppen tillgång
DOI
10.1016/j.lanepe.2023.100594
FinnDiane Study Grp; Harjutsalo, Valma; Kallio, Milla; Forsblom, Carol; Groop, Per-Henrik
The Lancet regional health : Europe2023

Isolating Urinary Extracellular Vesicles as Biomarkers for Diabetic Disease

Referentgranskad
DOI
10.1007/978-1-4939-9841-8
2020

1H NMR Metabonomics of Serum - Assessment of Molecular Indicators for Diabetic Nephropathy in Type 1 Diabetic Patients

Referentgranskad
2006

Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum

Referentgranskad
DOI
10.1007/s10334-006-0054-y
2006

Luteolin attenuates diabetic nephropathy via inhibition of metalloenzymes in rats

Referentgranskad
Öppen tillgång
DOI
10.4103/2221-1691.391156
2023

Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes

Referentgranskad
Öppen tillgång
DOI
10.1111/joim.13298
2021

Lipoproteins and Diabetic Nephropathy

Referentgranskad
DOI
10.1007/978-1-4614-7554-514
2014

Metabolic Phenotyping of Diabetic Nephropathy

Referentgranskad
2013

Metabolic phenotyping of diabetic nephropathy

Referentgranskad
DOI
10.1038/clpt.2013.158
2013

Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.

Referentgranskad
2009

The impact of diabetic nephropathy and severe diabetic retinopathy on chronic limb threatening ischemia risk in individuals with type 1 diabetes:a nationwide, population

Referentgranskad
Öppen tillgång
DOI
10.1016/j.lanepe.2023.100594
2023